Laird Norton Wetherby Wealth Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-18,050
Closed -$3.2M 766
2020
Q1
$3.2M Buy
18,050
+12,811
+245% +$2.41M 0.36% 58
2019
Q4
$1M Sell
5,239
-12,138
-70% -$2.19M 0.1% 214
2019
Q3
$2.92M Buy
17,377
+1,738
+11% +$283K 0.31% 71
2019
Q2
$2.62M Sell
15,639
-238
-1% -$33K 0.29% 77
2019
Q1
$2.33M Buy
15,877
+653
+4% +$94.7K 0.29% 77
2018
Q4
$2.04M Sell
15,224
-2,229
-13% -$365K 0.29% 75
2018
Q3
$3.32M Buy
17,453
+1,816
+12% +$334K 0.41% 48
2018
Q2
$2.61M Sell
15,637
-10,020
-39% -$1.61M 0.35% 61
2018
Q1
$4.32M Buy
25,657
+1,142
+5% +$192K 0.6% 27
2017
Q4
$4.01M Sell
24,515
-2,556
-9% -$459K 0.56% 34
2017
Q3
$5.55M Buy
27,071
+314
+1% +$73K 0.83% 18
2017
Q2
$6.5M Sell
26,757
-784
-3% -$184K 1.11% 11
2017
Q1
$6.58M Buy
27,541
+2,067
+8% +$481K 1.18% 9
2016
Q4
$5.35M Sell
25,474
-2,149
-8% -$445K 1.05% 13
2016
Q3
$6.36M Buy
27,623
+1,134
+4% +$277K 1.29% 9
2016
Q2
$6.12M Sell
26,489
-167
-0.6% -$38.5K 1.36% 9
2016
Q1
$7.14M Sell
26,656
-210
-0.8% -$60.1K 1.68% 7
2015
Q4
$8.39M Buy
26,866
+179
+0.7% +$53.3K 2.01% 5
2015
Q3
$7.25M Buy
26,687
+130
+0.5% +$39.9K 1.86% 5
2015
Q2
$8.06M Sell
26,557
-159
-0.6% -$47.4K 1.94% 4
2015
Q1
$7.95M Buy
26,716
+2,584
+11% +$737K 1.94% 5
2014
Q4
$6.21M Buy
24,132
+551
+2% +$138K 1.56% 9
2014
Q3
$5.69M Buy
23,581
+1,374
+6% +$307K 1.59% 9
2014
Q2
$4.95M Buy
22,207
+115
+0.5% +$23.8K 1.4% 9
2014
Q1
$4.55M Buy
22,092
+221
+1% +$43.8K 1.3% 10
2013
Q4
$3.67M Buy
21,871
+83
+0.4% +$13K 1.05% 16
2013
Q3
$3.14M Buy
21,788
+23
+0.1% +$3.06K 0.98% 19
2013
Q2
$2.75M Buy
+21,765
New +$2.46M 0.96% 21

Other funds holding AGN

Laird Norton Wetherby Wealth Management's AGN Position: Q2 2020 in Review

Laird Norton Wetherby Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 18,050 shares — an estimated $3.2M sold.

Laird Norton Wetherby Wealth Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $8.39M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Laird Norton Wetherby Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 18,050 Allergan plc shares in Q2 2020, an estimated $3.2M.
  • Laird Norton Wetherby Wealth Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Laird Norton Wetherby Wealth Management's Allergan plc position peaked at $8.39M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.